Detalles de la búsqueda
1.
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
Cell
; 182(6): 1401-1418.e18, 2020 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810439
2.
Forget lung, breast or prostate cancer: why tumour naming needs to change.
Nature
; 626(7997): 26-29, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347121
3.
Intratumoral Immunotherapy: Is It Ready for Prime Time?
Curr Oncol Rep
; 25(8): 857-867, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129706
4.
Patterns of progression in patients treated for immuno-oncology antibodies combination.
Cancer Immunol Immunother
; 70(1): 221-232, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700090
5.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Ann Rheum Dis
; 80(1): 36-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32327425
6.
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Lancet Oncol
; 21(10): 1353-1365, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919526
7.
Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.
Oncologist
; 25(5): 369-374, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32091646
8.
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
Eur J Nucl Med Mol Imaging
; 47(10): 2301-2312, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32206839
9.
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade.
Br J Cancer
; 120(1): 3-5, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413824
10.
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.
Eur J Nucl Med Mol Imaging
; 46(11): 2298-2310, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31346755
11.
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Lancet Oncol
; 19(9): 1180-1191, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120041
12.
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol
; 68(6): 1181-1190, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427729
13.
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
Ann Rheum Dis
; 76(10): 1747-1750, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600350
14.
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.
Blood
; 123(5): 678-86, 2014 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24326534
15.
[PD-L1 expression: An emerging biomarker in non-small cell lung cancer]. / Évaluation de l'expression de PD-L1 en immunohistochimie : un biomarqueur émergent dans les carcinomes pulmonaires non à petites cellules.
Ann Pathol
; 36(1): 94-102, 2016 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-26778219
16.
Tumour mutational burden in treatment-resistant tumours - Authors' reply.
Lancet Oncol
; 21(12): e552, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33271109
17.
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.
Strahlenther Onkol
; 191(7): 604-12, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25896312
18.
Paradigm shift in oncology: targeting the immune system rather than cancer cells.
Mutagenesis
; 30(2): 205-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25688113
19.
Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy.
Pediatr Blood Cancer
; 62(8): 1317-25, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25808079
20.
Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"
J Hepatol
; 70(3): 566-567, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30527952